Shorter Injectable-containing MDR/RR-TB Regimen: Pre-treatment evaluation and follow-up
H5Content
Shorter Injectable-containing MDR/RR-TB Regimen: Pre-treatment evaluation and follow-up
Shorter Injectable-containing MDR/RR-TB Regimen: Pre-treatment evaluation and follow-up
DR-TB Treatment in Pregnancy: General Considerations
DR-TB Treatment in Pregnancy: General Considerations
Immune Reconstitution Inflammatory Syndrome [IRIS]
Immune Reconstitution Inflammatory Syndrome
Common or Relevant Adverse Effects of DR-TB Therapy
Common or Relevant Adverse Effects of DR-TB Therapy
Management of QT Prolongation by Grade of Severity of ADR
Management of QT Prolongation by Grade of Severity of ADR
Management of Prolonged QTcF During Treatment with Shorter/Longer Oral MDR-TB Regimen
Management of Prolonged QTcF During Treatment with Shorter/Longer Oral MDR-TB Regimen
State PMDT Committee: Terms of Reference [ToR]
- Read more about State PMDT Committee: Terms of Reference [ToR]
- Log in to post comments
State Programmatic Management of Drug-resistant TB (PMDT) Committee
State Airborne Infection Control [AIC] Committee: Terms of Reference [ToR]
State Airborne Infection Control [AIC] Committee: Terms of Reference [ToR]
Management of Hepato-toxicity During Treatment with H Mono/Poly DR-TB Regimen
Management of Hepato-toxicity During Treatment with H Mono/Poly DR-TB Regimen